在轻度认知障碍中,抑郁症状与认知表现之间的横截面和纵向关联
Calum A Hamilton1, Paul C Donaghy1, John-Paul Taylor1
1Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
概括
在轻度认知障碍 (MCI) 中,抑郁症状会严重影响认知功能. 解决这些症状可能会揭示真正的认知能力并支持长期的大脑健康.
科学领域:
- 神经科学
- 老年学
- 精神病学
背景情况:
- 在轻度认知障碍 (MCI) 中,抑郁症状很常见.
- 这些症状与认知功能下降和痴呆风险增加有关.
- 这项研究侧重于没有主要情绪障碍的神经退行性MCI.
研究的目的:
- 调查与MCI抑郁症状变化相关的认知模式.
- 区分基于状态和基于特征的关联.
- 通过时间探索对认知轨迹的影响.
主要方法:
- 每年对123名患有MCI (阿尔茨海默病或勒维体痴呆症) 的患者进行评估.
- 使用阿登布鲁克认知检查-修订测量认知功能.
- 使用老年抑郁症尺度-15进行了抑郁症状评估.
主要成果:
- 在人体内抑郁症状变化与同时认知表现之间发现了显著的负相关性.
- 抑郁症得分增加2分相当于认知得分下降1分.
- 没有证据支持基于特征的关联或抑郁症状的轨迹改变.
结论:
- 抑郁症症状严重程度的急性变化与即时的认知能力波动相关.
- 在抑郁症期间的认知评估可能不反映个体的基线认知能力.
- 治疗MCI抑郁症状可以提高认知能力的准确性,并保持功能.
相关概念视频
Negative and Cognitive Symptoms of Schizophrenia
123
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
123
Cognitive Development During Adulthood
267
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
267
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
Depressive Disorders: MDD and Dysthymia
212
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
212
Language and Cognition
440
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
440
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666


